LEA Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Execution CNTB Q1 2026 Earnings Deeper Than Expected Losses as Biotech Continues PreRevenue Phase CVLT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response ESRT Q1 2026 Earnings Stable EPS Amid Market Uncertainty as Stock Slips RDZN Q1 2026 Earnings Deep EPS Miss and Revenue Disclosure Gap Autolus Therapeutics Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment